Nanjing Quzyme Biotechnology
Synthetic biology-driven green biomanufacturing of enzyme catalysts
About Nanjing Quzyme Biotechnology
Nanjing Quzyme Biotechnology Co., Ltd. is a high-tech enterprise focused on the research and development, production, and sale of special enzymes and functional chemicals. The company leverages synthetic biology to drive green biomanufacturing processes.
Founded in 2014, the company operates with a business model centered on providing enzyme catalysts and technology solutions for various industries. Its clientele includes sectors such as pharmaceuticals, food and beverage, and new materials. By utilizing advanced biocatalysis technology, Quzyme Biotechnology aims to replace traditional chemical synthesis methods, offering more environmentally friendly and efficient production routes. The company generates revenue through the direct sale of its enzyme products and by providing customized biocatalytic technology development services to its clients.
In July 2023, Nanjing Quzyme Biotechnology secured approximately CNY 100 million in a Series A financing round. The investment was led by a consortium of venture capital firms including Hermed Capital, Kangju Venture Capital, Nanling Venture Capital, KYT Investment, Solid Investment, and Huayao Equity, indicating strong investor confidence in its technology and market potential.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Open positions
- None listed
- Dealroom signal
- 12.0/100
- Links
- Website
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Jul 2023 | $14M | $55M | Kangju Venture Capital · KYT Investment · Huayao Equity · Hermed Capital | ↗ |
Growth signals
Latest recorded traffic for Nanjing Quzyme Biotechnology is 450 monthly website visits, down 67.9% over the last three months.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Nanjing Quzyme Biotechnology in its local ecosystem
The Nanjing Quzyme Biotechnology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A6 investors entered at this stage
- KCKangju Venture Capital
- KIKYT Investment
- HEHuayao Equity
- HCHermed Capital
- NCNanling Venture Capital
- SISolid Investment
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Nanjing Quzyme Biotechnology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Nanjing Quzyme Biotechnology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.